4.8 Article

Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections

Journal

NATURE COMMUNICATIONS
Volume 3, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms1677

Keywords

-

Funding

  1. Ministry of Health, Labour and Welfare of Japan [H22-Shinkou-Ippan-013]
  2. Japan Society for the Promotion of Science [22790959]
  3. Grants-in-Aid for Scientific Research [22591116, 20790345, 22790959] Funding Source: KAKEN

Ask authors/readers for more resources

Cytokine-activated neutrophils are known to be essential for protection against group A Streptococcus infections. However, during severe invasive group A Streptococcus infections that are accompanied by neutropenia, it remains unclear which factors are protective against such infections, and which cell population is the source of them. Here we show that mice infected with severe invasive group A Streptococcus isolates, but not with non-invasive group A Streptococcus isolates, exhibit high concentrations of plasma interferon-gamma during the early stage of infection. Interferon-gamma is necessary to protect mice, and is produced by a novel population of granulocyte-macrophage colony-stimulating factor-dependent immature myeloid cells with ring-shaped nuclei. These interferon-gamma-producing immature myeloid cells express monocyte and granulocyte markers, and also produce nitric oxide. The adoptive transfer of interferon-gamma-producing immature myeloid cells ameliorates infection in wild-type and interferon-gamma-deficient mice. Our results indicate that interferon-gamma-producing immature myeloid cells have a protective role during the early stage of severe invasive group A Streptococcus infections.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018

Tadayoshi Ikebe, Rumi Okuno, Yoshiko Kanda, Mari Sasaki, Takahiro Yamaguchi, Hitoshi Otsuka, Yu Kazawa, Miyuki Suzuki, Hitomi Ohya, Kaoru Uchida, Makoto Ohnishi

Summary: The study identified the prevalent emm types among STSS patients in Japan from 2013 to 2018, with emm1 being the most common followed by emm89, emm12, and emm3. The proportions of emm3 and emm89 increased over time, while emm1 decreased. Some emm types showed increasing prevalence and were not previously isolated from STSS patients. Additionally, an emm76 type increased in prevalence and was not included in the 30-valent M protein-based vaccine, highlighting the importance of continued surveillance for changes in GAS epidemiology for future vaccination strategies and antimicrobial resistance monitoring.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2021)

Article Cell Biology

Association of HLA-DRB1*09:01 with severe COVID-19

Alitzel Anzurez, Izumi Naka, Shoji Miki, Kaori Nakayama-Hosoya, Mariko Isshiki, Yusuke Watanabe, Midori Nakamura-Hoshi, Sayuri Seki, Takayuki Matsumura, Tomohiro Takano, Taishi Onodera, Yu Adachi, Saya Moriyama, Kazutaka Terahara, Natsuo Tachikawa, Yoshihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Kazuhito Miyazaki, Michiko Koga, Kazuhiko Ikeuchi, Hiroyuki Nagai, Makoto Saito, Eisuke Adachi, Hiroshi Yotsuyanagi, Satoshi Kutsuna, Akira Kawashima, Yusuke Miyazato, Noriko Kinoshita, Chiyoko Kouno, Kensuke Tanaka, Yoshimasa Takahashi, Tadaki Suzuki, Tetsuro Matano, Jun Ohashi, Ai Kawana-Tachikawa

Summary: The study found a significant association between the HLA-DRB1*09:01 allele and severe COVID-19, with a higher risk compared to preexisting medical conditions such as hypertension, diabetes, and cardiovascular diseases. These results suggest a potential role for HLA in predisposing individuals to severe COVID-19.
Article Immunology

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama, Yu Adachi, Takashi Sato, Keisuke Tonouchi, Lin Sun, Shuetsu Fukushi, Souichi Yamada, Hitomi Kinoshita, Kiyoko Nojima, Takayuki Kanno, Minoru Tobiume, Keita Ishijima, Yudai Kuroda, Eun-Sil Park, Taishi Onodera, Takayuki Matsumura, Tomohiro Takano, Kazutaka Terahara, Masanori Isogawa, Ayae Nishiyama, Ai Kawana-Tachikawa, Masaharu Shinkai, Natsuo Tachikawa, Shigeki Nakamura, Takahiro Okai, Kazu Okuma, Tetsuro Matano, Tsuguto Fujimoto, Ken Maeda, Makoto Ohnishi, Takaji Wakita, Tadaki Suzuki, Yoshimasa Takahashi

Summary: Antibody titers against SARS-CoV-2 decrease over time, but the neutralizing potency against the original virus and variants actually improves with time. Late convalescent antibodies show increased neutralization potency against variants, suggesting that antibody response maturation enhances cross-neutralizing ability against circulating variants. This indicates that declining antibody titers may not necessarily mean declining protection.

IMMUNITY (2021)

Article Immunology

SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine

Ryutaro Kotaki, Yu Adachi, Saya Moriyama, Taishi Onodera, Shuetsu Fukushi, Takaki Nagakura, Keisuke Tonouchi, Kazutaka Terahara, Lin Sun, Tomohiro Takano, Ayae Nishiyama, Masaharu Shinkai, Kunihiro Oba, Fukumi Nakamura-Uchiyama, Hidefumi Shimizu, Tadaki Suzuki, Takayuki Matsumura, Masanori Isogawa, Yoshimasa Takahashi

Summary: Multiple SARS-CoV-2 variants, particularly Beta and Omicron, have the potential to evade neutralizing antibodies, even in those who have received two doses of the BNT162b2 mRNA vaccine. However, boosting with a third vaccine dose or breakthrough infection can improve the overall breadth of neutralizing antibodies. This study longitudinally profiles the cellular composition of RBD-binding memory B cell subsets and their antibody binding and neutralizing activity after the second dose of mRNA vaccine. It finds that two doses of mRNA vaccine induce an expanded antibody breadth over time, while a subset of resting memory B cells show the ability to produce Beta and Omicron-neutralizing antibodies.

SCIENCE IMMUNOLOGY (2022)

Article Virology

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir

Kanako Shinada, Takashi Sato, Saya Moriyama, Yu Adachi, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Masamichi Mineshita, Takayuki Matsumura, Yoshimasa Takahashi, Masaharu Shinkai

Summary: The use of favipiravir in the treatment of COVID-19 accelerates viral clearance, preserves the generation and persistence of neutralizing antibodies, and does not interfere with the maturation of neutralizing potency against both WT SARS-CoV-2 and its variants.

VIRUSES-BASEL (2022)

Article Medicine, General & Internal

Natural mutation in the regulatory gene (srrG) influences virulence-associated genes and enhances invasiveness in Streptococcus dysgalactiae subsp. equisimilis strains isolated from cases of streptococcal toxic shock syndrome

Tadayoshi Ikebe, Hitoshi Otsuka, Kazuki Chiba, Yu Kazawa, Takahiro Yamaguchi, Rumi Okuno, Yoshimi Date, Mari Sasaki, Junko Isobe, Makoto Ohnishi, Yukihiro Akeda

Summary: This study identified csrS/csrR and srrG gene mutations that are associated with increased virulence gene expression in STSS-SDSE isolates. Strains carrying these mutations exhibited enhanced pathogenicity in mice. The higher frequency of mutations observed in STSS-SDSE isolates highlights their importance in STSS.

EBIOMEDICINE (2022)

Article Multidisciplinary Sciences

SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype

Kazutaka Terahara, Takashi Sato, Yu Adachi, Keisuke Tonouchi, Taishi Onodera, Saya Moriyama, Lin Sun, Tomohiro Takano, Ayae Nishiyama, Ai Kawana-Tachikawa, Tetsuro Matano, Takayuki Matsumura, Masaharu Shinkai, Masanori Isogawa, Yoshimasa Takahashi

Summary: The determinants of memory T cell longevity following SARS-CoV-2 infection are still unknown. This study found that the half-lives of CD4(+) and CD8(+) T cells were longer than antibody titers. Th17-like subset of CD4(+) T cells showed the longest half-life, indicating its close association with T cell longevity. In contrast, Th2 and Tfh-like T cells were more closely correlated with antibody levels.

ISCIENCE (2022)

Article Multidisciplinary Sciences

Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan

Yukie Kashima, Taketoshi Mizutani, Kaori Nakayama-Hosoya, Saya Moriyama, Takayuki Matsumura, Yoshihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Kazuhito Miyazaki, Natsuo Tachikawa, Yoshimasa Takahashi, Tadaki Suzuki, Sumio Sugano, Tetsuro Matano, Ai Kawana-Tachikawa, Yutaka Suzuki

Summary: Through the analysis of single-cell transcriptome and T cell receptor repertoire, differences in cell proportions and gene expression profiles were found between mild and severe cases of COVID-19, as well as among severe cases. In a severely infected elderly patient, characteristics such as depletion of naive T cells, low T cell receptor repertoire diversity, and aberrant hyperactivation of immune cell subsets were observed. This study provides valuable insights into the diversity of immune landscapes and responses.

SCIENTIFIC REPORTS (2023)

Article Infectious Diseases

Proposed Algorithm for Integrated Management of TB-SARS-CoV-2 Co-Infection in a TB-Endemic Country

Ni Made Mertaniasih, Soedarsono Soedarsono, Tiffany Tiara Pakasi, Zakiyathun Nuha, Manabu Ato

Summary: This research aims to investigate the impact of TB-SARS-CoV-2 co-infection and propose a conceptual strategy for an integrated management system. The system includes early detection and synchronization of TB-COVID-19 health services, providing important insights for future strategies.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2022)

Article Immunology

Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site

Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Takayuki Matsumura, Yoshimasa Takahashi, Isao Hamaguchi

Summary: The mechanisms of how non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs are clarified in this study. The combination of systemic inoculation with type 1 interferon (IFN)-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection. These results provide insights into novel mucosal vaccine strategies using non-mucosal inoculated adjuvants.

MUCOSAL IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain

Tomohiro Takano, Takashi Sato, Ryutaro Kotaki, Saya Moriyama, Shuetsu Fukushi, Masahiro Shinoda, Kiyomi Kabasawa, Nagashige Shimada, Mio Kousaka, Yu Adachi, Taishi Onodera, Kazutaka Terahara, Masanori Isogawa, Takayuki Matsumura, Masaharu Shinkai, Yoshimasa Takahashi

Summary: Takano et al. demonstrate that a heterologous booster using a SARS-CoV-2 recombinant spike protein vaccine induces a more sustained and broader anti-spike receptor-binding domain antibody response compared to a homologous booster using an mRNA vaccine. The study shows that the S-268019-b spike protein booster generates higher and longer-lasting IgG titers specific to the SARS-CoV-2 spike receptor-binding domain, with the ability to bind to antigenically distinct variants, while the BNT162b2 mRNA homologous booster has a weaker effect. Additionally, the S-268019-b booster enhances the production of RBD-angiotensin-converting enzyme 2 (ACE2) binding inhibitory antibodies, resulting in increased neutralizing activities against Omicron BA.1 and BA.5 variants.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes

Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, Ryo Shinnakasu, Takayuki Nakagawa, Shuetsu Fukushi, Tommy Terooatea, Mai Yoshikawa, Keisuke Tonouchi, Takaki Nagakura, Saya Moriyama, Takayuki Matsumura, Masanori Isogawa, Kazutaka Terahara, Tomohiro Takano, Lin Sun, Ayae Nishiyama, Shinnya Omoto, Masaharu Shinkai, Tomohiro Kurosaki, Kazuo Yamashita, Yoshimasa Takahashi

Summary: By analyzing single Bmem cells and assessing antibody function, we have identified the characteristics of Bmem cells that carry potent neutralizing antibodies in COVID-19 convalescent individuals. These neutralizing antibodies are marked by elevated CD62L expression, distinct epitope preference, and usage of convergent VH genes, which contribute to their neutralizing activities. Despite equivalent receptor binding, there is a correlation between neutralizing antibody titers and the CD62L+ subset. Moreover, the dynamics of the CD62L+ subset differ among patients with varying COVID-19 severities. Our Bmem cell profiling reveals the unique phenotype of the subset harboring potent neutralizing BCRs and enhances our understanding of humoral protection.

SCIENCE ADVANCES (2023)

Article Microbiology

Serotype Distribution and Antimicrobial Resistance of Streptococcus agalactiae Isolates in Nonpregnant Adults with Streptococcal Toxic Shock Syndrome in Japan in 2014 to 2021

Tadayoshi Ikebe, Rumi Okuno, Yumi Uchitani, Mami Takano, Takahiro Yamaguchi, Hitoshi Otsuka, Yu Kazawa, Shohei Fujita, Ayaka Kobayashi, Yoshimi Date, Junko Isobe, Emi Maenishi, Makoto Ohnishi, Yukihiro Akeda

Summary: The incidence of streptococcal toxic shock syndrome (STSS) caused by group B Streptococcus (GBS) is increasing annually in Japan. Penicillin- or clindamycin-resistant strains used to treat STSS have been reported. This study analyzed 268 GBS strains isolated from nonpregnant adult patients with STSS in Japan between 2014 and 2021. The most prevalent serotype was Ib, and a significant number of isolates were resistant to penicillin and clindamycin. The introduction of the GBS vaccine is essential for disease prevention.

MICROBIOLOGY SPECTRUM (2023)

Article Cell Biology

Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine

Tomohiro Takano, Miwa Morikawa, Yu Adachi, Kiyomi Kabasawa, Nicolas Sax, Saya Moriyama, Lin Sun, Masanori Isogawa, Ayae Nishiyama, Taishi Onodera, Kazutaka Terahara, Keisuke Tonouchi, Masashi Nishimura, Kentaro Tomii, Kazuo Yamashita, Takayuki Matsumura, Masaharu Shinkai, Yoshimasa Takahashi

Summary: By applying high-dimensional immune profiling, the study identified vaccine-induced immune dynamics that correlate with neutralizing antibody levels, adverse event severity, or both. Natural killer cells, dendritic cell subsets, and NKT-like cells were found to play important roles in these immune dynamics.

CELL REPORTS MEDICINE (2022)

Article Parasitology

Evaluation of the stability of Yamakagashi (Rhabdophis tigrinus) Equine Antivenom after 20 years storage

K. Morokuma, T. Matsumura, A. Yamamoto, A. Sakai, T. Hifumi, M. Ato, M. Takahashi

Summary: The equine Yamakagashi antivenom manufactured in 2000 as an unapproved drug showed strong neutralizing ability against the venom's activity and remained stable and effective after 20 years, passing quality control tests and maintaining potency and safety within standard values.

TROPICAL BIOMEDICINE (2021)

No Data Available